Tracy, 56, lives in Northeast Ohio with her wife of 12 years, Julie. Julie was diagnosed in 2014 with stage three clear cell renal cell carcinoma.
For this month’s Community Spotlight, KidneyCAN spoke to Tracy, whose wife Julie is living with stage four kidney cancer. Tracy shares their experiences from a caregiver perspective, emphasizing the importance of patient advocacy, a second set of ears, and caregiver mental health.

A Year Like No Other

Please tell us a little about your story and your experience in finding the best medical care for Julie.

2014 was quite a year for my wife Julie and me. Her symptoms, which began in January while we were on vacation, included dizziness and high blood pressure.

Over the course of six months, Julie was seen by a variety of doctors across several states as we traveled and tried to go about our normal lives. At one point, she was so dizzy that we went to an emergency room while visiting family in Northern California. After two days in the stroke unit, where everything but her abdomen and pelvis were scanned, Julie was discharged with a diagnosis of anxiety.

We found a new primary care doctor back home in rural New Hampshire, and Julie finally had a CT scan on her 59th birthday. That scan revealed a 5 cm mass on her left kidney.

While it was a relief to get an answer, and a profound lesson in patient advocacy, we both knew how serious this was and how important it is to get the very best care. My sister had undergone a nephrectomy just 3 years earlier at the Cleveland Clinic. Her procedure was difficult, and she may not have survived if she hadn’t been at a world-class facility. Julie and I agreed that going to Cleveland for a urology consultation was the best approach, so we scheduled an appointment and drove 600 miles to Ohio.

The surgeon recommended a laparoscopic nephrectomy, which he performed the next week with no complications. Even before she received the official diagnosis of stage three clear cell renal cell carcinoma, we discussed the likelihood of the cancer recurring. We wondered how we would manage living year-round in our New Hampshire lake house, far from a major medical center.

Therefore, while Julie was recovering from surgery, we decided to move and made an offer on a house in Ohio. We ended 2014 with one less kidney, and one more house!

A New Role: Caregiver

Can you describe your experiences caring for your wife? 

Being a caregiver was a new role for me and not one I expected to be very good at performing. After the panic of the diagnosis, I struggled with not being able to “fix” this.

Julie and I are fortunate to be able to talk honestly with each other, which helped us to accept that both of our lives had changed. Throughout this entire process, we have been able to work together to adapt to each new reality.

Planning and strategizing come naturally to me, so it gives me some sense of control to deal with “cancer admin,” such as scheduling, insurance, and pharmacies. This also gives Julie the freedom to focus on activities that are important to her, such as working in her art studio.

The most difficult aspect of treatment with axi/pembro has been dealing with all of the side effects and trying to maintain a good quality of life. So far, I have been at every appointment with Julie. I keep a detailed planner to update the care team and various specialists about any new symptoms or concerns.  

What advice might you offer to a patient or spouse of someone newly diagnosed with kidney cancer? 

It’s okay to be overcome with a range of emotions initially. Fear and shock are normal, but so are anger, resentment, and even anticipatory grief. Nobody planned for this and the future looks uncertain. Go ahead and feel these things.

However, the sooner you accept the situation, the sooner you can begin to move forward and help your loved one. Caregiving presents challenges for even the most resilient people, so try to find ways to stay mentally healthy. If you are unable to cope effectively, reach out to people for help and support.

“Being there for appointments and infusions is an important aspect of caregiving, because the patient may not be feeling great or be able to keep track of what is discussed. It’s true that the extra set of ears is crucial.”

– Tracy, wife and caregiver

Julie is a photographer and collagist who taught art for nearly three decades and has traveled all over the world.  She continues her art work as much as possible while undergoing treatment.
Tracy retired in 2021 and enjoys collecting fountain pens, reading European history, and watching old movies.

The Decision to Move Closer to Care

What can you share about the decision to move for care?

We had watched friends in New Hampshire deal with cancer and the difficulties of access and transportation, as well as finding doctors who were up-to-date on the newest treatments. We were also at a point in our lives where we were contemplating a move; Julie was an art teacher for 30 years and had retired in 2011, so we could be flexible. After her surgery, we looked at the odds of progressing to stage four and agreed that having a world-class hospital system nearby made good sense for us.

When the cancer was found in her lungs in August of 2017, she began seeing Dr. Brian Rini, who advised active surveillance. In fact, she was still under his care in April 2019 when the FDA approved the axi/pembro combo based on KEYNOTE-426. In December of 2019, Dr. Moshe Ornstein took over Julie’s case, and she enjoyed a total of 38 months of surveillance before the cancer progression required treatment in October of 2020.

We have been very satisfied with our decision to come to the Cleveland Clinic. The staff are so caring and have deep knowledge and experience with kidney cancer. A few years ago, when Julie was hospitalized for another reason at a different facility, an oncologist there saw her records, told her she had kidney cancer, and said she needed to start taking Sutent immediately, which would not have been the best choice for Julie’s condition. She had indolent disease and did not actually need systemic treatment yet. We have seen firsthand the necessity of advocating for your health and finding kidney cancer specialists.

“Palpable Enthusiasm” for the Future

What made you decide to become an advocate for kidney cancer research funding?

I discovered KidneyCAN and Smart Patients several years ago, and the information from both sources has been incredibly valuable to us. After taking early retirement in 2021, I was free to spend some of my time engaging in advocacy. Many patients do not have the resources or energy to advocate for themselves, so this is one small contribution I can make on their behalf.

It has been almost eight years since Julie’s original diagnosis, and since that time, the treatment landscape has been revolutionized. The enthusiasm among kidney cancer specialists about the future is palpable – they just need the funding to conduct the research that will move us closer to a cure.

The Impact of KCRP on Patients

What would you like clinicians and researchers to know about the Kidney Cancer Research Program (KCRP) award process and how these High Risk/High Reward programs impact patients? 

Since its creation in 2017, the KCRP has awarded $135 million to further its mission of promoting high impact research in kidney cancer. However, annual funding is not guaranteed and must be approved by Congress each fiscal year. Patients and their families are eager for major breakthroughs in treatment – giant leaps instead of baby steps – and the KCRP program offers researchers the opportunity to test innovative approaches that will advance current standards of care.

Optimism on Hard Days

What is something that motivates or inspires you on harder days?

There are some exceptionally compassionate and brilliant people engaged in kidney cancer research and treatment. Their optimism helps when we are going through a rough time with side effects and day-to-day hurdles. It’s also helpful to remind myself that we are very fortunate in many ways, and I don’t take the good things for granted.

We at KidneyCAN sincerely thank Tracy for telling her story and offering her insights to our community of patients, caregivers, doctors, and researchers. Thank you for your advocacy.

Stay in the loop with KidneyCAN news and research! Subscribe to our newsletter here:

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...